GoodRx Holdings Overview

GoodRx Holdings Cost of Revenue

Cost of Revenue analysis for GDRX.

Quarterly Cost of Revenue

$20.16M

↑ 50.82% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$64.39M

↑ 31.11% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin